LGND Competitors & Alternatives
Compare Ligand Pharmaceuticals Incorporated with similar stocks in the same industry
Biotechnology
LGND
Main Stock$302.96
Tradestie Score
44
Market Cap
$3.49B
P/E Ratio
32.1
Revenue Growth
0.3%
Analyst Upside
+13.6%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CYTK
Cytokinetics Inc.
|
$65.60
|
$6.68B | - | 63 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$92.83
|
$6.64B | - | 46 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$92.88
|
$6.38B | - | 67 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.57
|
$6.03B | - | 46 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$55.43
|
$6.02B | - | 54 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$179.25
|
$5.92B | - | 42 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.29
|
$5.80B | 20.4 | 34 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$322.28
|
$5.20B | 40.8 | 63 | Compare |
|
ALKS
Alkermes Inc. plc
|
$41.75
|
$5.06B | 106.7 | 62 | Compare |
More LGND Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry